Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
about
The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the gamesRegulation and localization of endogenous human tristetraprolinCrystalline monoclonal antibodies for subcutaneous delivery.Antibodies as therapeutic agents: vive la renaissance!Microfluidics for T- lymphocyte cell separation and inflammation monitoring in burn patients.Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitisCytokine-based immunointervention in the treatment of autoimmune diseases.Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNFInnate pathways to B-cell activation and tolerance.InforMatrix: treatment of rheumatoid arthritis using biologicals.Cytokine levels in the serum of healthy subjectsHuman immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cellsA review of CT-P13: an infliximab biosimilar.Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease.Paradoxical response during antituberculous therapy in a patient discontinuing infliximab: a case report.Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.First study of infliximab treatment in patients with chronic obstructive pulmonary disease.Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.[Clinical experience with the use of infliximab in 44 patients with Crohn's disease].Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease.Chronic rhinosinusitis and psoriasis: do mutually exclusive systemic Th1 and Th2 disease patterns exist?
P2860
Q24683018-B399E3D6-1B81-4E3E-AA9F-800AC2F96059Q24805049-6EEBD11D-0638-4F12-AAB1-9437F4A45A34Q30478345-BB2F86D9-95F8-4D3C-9C8E-FCFB08751CE3Q33193524-3B6F05A8-8690-4141-9940-5756373A39BBQ34669933-1A5CE4B4-B931-4EF2-89E7-2CD7C3DF3970Q35019838-9861ACAC-FECD-4542-A1FD-EC83C46670D8Q35109131-D679723E-9BB1-4D68-822F-FAA223F88F5CQ35553478-7FC2B2C1-B567-4B93-9930-A975B28C247EQ36172913-8F1C9A8F-8798-4559-B9D0-416D4A7C4D98Q36573901-7FDD0D5F-1A1E-4C84-ACDC-338918D8E170Q36711758-279AA475-58F2-4F31-BD41-6CA84BC78491Q36845582-560B579B-285F-42EF-A2D7-0EE568BAA40DQ38203821-1AFFF2E7-CBCD-4577-BCC7-A45E228ABEC5Q39684886-C540661C-9390-4214-835B-539B4BB73D4CQ40376849-93FCEB46-7AE1-4380-B3EF-9B85242E4B60Q42704864-4110C3AB-0FE9-45C8-A64A-EB493FCD6E8DQ47785823-6441C01D-F684-46A3-BDB8-F8AB67F2618AQ48629879-998B9D9A-080D-4BA4-8A10-B3C42B10A1EEQ53262331-66B1FE99-06A0-4A53-BDF8-7AB21BB2DA2FQ53900512-2878EE80-E497-4EE3-A56B-7AF2C8EC8C33Q54560954-6ED3434F-6247-4AFB-B6AC-C5A5454F2B5CQ58290775-0A327606-3B23-4001-80C6-C1BCD2FA7D66
P2860
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
@ast
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
@en
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
@nl
type
label
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
@ast
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
@en
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
@nl
prefLabel
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
@ast
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
@en
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
@nl
P1433
P1476
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
@en
P304
P356
10.2165/00063030-200216020-00005
P577
2002-01-01T00:00:00Z
P6179
1042057938